{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:08:11Z","timestamp":1784106491815,"version":"3.55.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To characterize variation in circulating vascular endothelial growth factor (VEGF) and its receptor, soluble fms-like tyrosine kinase-1 (sFLT-1), across the menstrual cycle in normal ovulating women in relation to reproductive hormones to identify the utility of VEGF and sFLT-1 as peripheral biomarkers of endometrial remodeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Ninety-six healthy, regularly menstruating ovulatory women, aged 18\u201344 years, enrolled in the BioCycle Study, a prospective cohort study at a U.S. academic research center. Vascular endothelial growth factor and sFLT-1 were measured in concurrently collected plasma, serum, and urine up to eight times across a single cycle. Reproductive hormones were measured in serum. Mean concentrations of VEGF and sFLT-1 were compared across phases of the cycle, and correlations between specimen types were calculated. Harmonic models estimated associations between VEGF and sFLT-1 and characteristics of hormonal patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>No variation in VEGF or sFLT-1 levels were detected over the menstrual cycle. Median (25th percentile, 75th percentile) concentrations of VEGF during the menstrual cycle were 31.2 pg\/mL (24.1, 56.9) in plasma, 194.1 pg\/mL (125.4, 350.2) in serum, and 101.7 pg\/mL (64.2, 165.8) in urine. Plasma and serum measures were consistently correlated, whereas urinary measures were not. Vascular endothelial growth factor was not consistently associated with reproductive hormone concentrations, although sFLT-1 was associated with higher mean and amplitude of estradiol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Circulating VEGF and sFLT-1 did not vary across the menstrual cycle and therefore are unlikely to be useful peripheral biomarkers of endometrial changes across the menstrual cycle. For studies measuring circulating VEGF for other reasons, plasma may be the preferred medium and timing to menstrual cycle phase need not be considered for reproductive-age women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004171","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T17:03:32Z","timestamp":1607015012000},"page":"82-90","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Circulating Vascular Endothelial Growth Factor and Soluble fms-Like Tyrosine Kinase-1 as Biomarkers for Endometrial Remodeling Across the Menstrual Cycle"],"prefix":"10.1097","volume":"137","author":[{"given":"Jessica R.","family":"Zolton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.","family":"Sjaarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunni L.","family":"Mumford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"DeVilbiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keewan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry S.","family":"Flannagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie G.","family":"Radoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Wactawski-Wende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"DeCherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique F.","family":"Schisterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"R1-20260601","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmv038","article-title":"Menstrual physiology: implications for endometrial pathology and beyond","volume":"21","author":"Maybin","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R2-20260601","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.gco.0000175362.12470.e0","article-title":"Vascular endothelial growth factor expression in the endometrium during the menstrual cycle, implantation window and early pregnancy","volume":"17","author":"Nardo","year":"2005","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R3-20260601","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/humrep\/deh810","article-title":"Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system","volume":"20","author":"Moller","year":"2005","journal-title":"Hum Reprod"},{"key":"R4-20260601","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/humrep\/del089","article-title":"Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia","volume":"21","author":"Malik","year":"2006","journal-title":"Hum Reprod"},{"key":"R5-20260601","first-page":"909","article-title":"Expression of vascular endothelial growth factor receptor-3 in the endometrium in menorrhagia","volume":"19","author":"Mints","year":"2007","journal-title":"Int J Mol Med"},{"key":"R6-20260601","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1159\/000437370","article-title":"The relationship between vascular endothelial growth factor 1154G\/A polymorphism and recurrent implantation failure","volume":"24","author":"Vagnini","year":"2015","journal-title":"Med Prin Pract"},{"key":"R7-20260601","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/14647273.2018.1524935","article-title":"Prevalence of candidate single nucleotide polymorphisms on p53, IL-11, IL-10, VEGF and APOE in patients with repeated implantation failure (RIF) and pregnancy loss (RPL)","volume":"23","author":"Turienzo","year":"2020","journal-title":"Human Fertil (Camb)"},{"key":"R8-20260601","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"R9-20260601","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1210\/jcem.84.6.5886","article-title":"Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: potential relevance to menstruation and endometrial regeneration","volume":"84","author":"Popovici","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20260601","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jri.2013.06.002","article-title":"A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling","volume":"101\u2013102","author":"Saito","year":"2014","journal-title":"J Reprod Immunol"},{"key":"R11-20260601","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/emmm.201302618","article-title":"VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy","volume":"5","author":"Kim","year":"2013","journal-title":"EMBO Mol Med"},{"key":"R12-20260601","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1071\/RD17184","article-title":"Expression of vascular endothelial growth factor A isoforms is dysregulated in women with endometriosis","volume":"30","author":"Danastas","year":"2018","journal-title":"Reprod Fertil Dev"},{"issue":"suppl 1","key":"R13-20260601","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.fertnstert.2005.11.029","article-title":"Human embryo-conditioned medium stimulates in vitro endometrial angiogenesis","volume":"85","author":"Kapiteijn","year":"2006","journal-title":"Fertil Steril"},{"key":"R14-20260601","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0015-0282(16)58390-3","article-title":"Vascular endothelial growth factor expression in cycling human endometrium","volume":"66","author":"Torry","year":"1996","journal-title":"Fertil Steril"},{"key":"R15-20260601","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1009292506879","article-title":"Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation","volume":"2","author":"Bausero","year":"1998","journal-title":"Angiogenesis"},{"key":"R16-20260601","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/molehr\/5.5.452","article-title":"Expression of mRNA for vascular endothelial growth factor transmembranous receptors Flt1 and KDR, and the soluble receptor sFLT in cycling human endometrium","volume":"5","author":"Kr\u00fcssel","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"R17-20260601","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.fertnstert.2003.10.025","article-title":"Circulating angiogenic factors during periovulation and the luteal phase of normal menstrual cycles","volume":"81","author":"Malamitsi-Puchner","year":"2004","journal-title":"Fertil Steril"},{"key":"R18-20260601","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2265.1999.00618.x","article-title":"Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow","volume":"50","author":"Agrawal","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R19-20260601","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/bjc.1998.655","article-title":"Vascular endothelial growth factor in premenopausal women\u2014indicator of the best time for breast cancer surgery?","volume":"78","author":"Heer","year":"1998","journal-title":"Br J Cancer"},{"key":"R20-20260601","first-page":"465","article-title":"Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancer","volume":"2","author":"Chung","year":"1998","journal-title":"Int J Mol Med"},{"key":"R21-20260601","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/sj.bjc.6600322","article-title":"A comparison of serum and plasma levels of vascular endothelial growth factor during the menstrual cycle in healthy female volunteers","volume":"86","author":"McIlhenny","year":"2002","journal-title":"Br J Cancer"},{"key":"R22-20260601","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/clinchem\/47.4.617","article-title":"Pitfalls in the measurement of circulating vascular endothelial growth factor","volume":"47","author":"Jelkmann","year":"2001","journal-title":"Clin Chem"},{"key":"R23-20260601","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-3016.2008.00985.x","article-title":"BioCycle study: design of the longitudinal study of the oxidative stress and hormone variation during the menstrual cycle","volume":"23","author":"Wactawski-Wende","year":"2009","journal-title":"Paediatric Perinat Epidemiol"},{"key":"R24-20260601","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.fertnstert.2014.04.035","article-title":"Assessment of anovulation in eumenorrheic women: comparison of ovulation detection algorithms","volume":"102","author":"Lynch","year":"2014","journal-title":"Fertil Steril"},{"key":"R25-20260601","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/aje\/kwn287","article-title":"Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study","volume":"169","author":"Howards","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R26-20260601","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-3016.2011.01204.x","article-title":"Realignment and multiple imputation of longitudinal data: an application to menstrual cycle data","volume":"25","author":"Mumford","year":"2011","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R27-20260601","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/aje\/kwj039","article-title":"The limitations due to exposure detection limits for regression models","volume":"163","author":"Schisterman","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R28-20260601","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/dmg024","article-title":"Obesity and reproductive disorders in women","volume":"9","author":"Pasquali","year":"2003","journal-title":"Hum Reprod Update"},{"key":"R29-20260601","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S0021932000012037","article-title":"Incidence of ovulatory cycles in women approaching the menopause","volume":"11","author":"Metcalf","year":"1979","journal-title":"J Biosoc Sci"},{"key":"R30-20260601","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/gme.0b013e318174ea4d","article-title":"Cycle and hormone changes during perimenopause: the key role of ovarian function","volume":"15","author":"Burger","year":"2008","journal-title":"Menopause"},{"key":"R31-20260601","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.8755-8920.2000.430105.x","article-title":"No cyclicity in serum vascular endothelial growth factor during normal menstrual cycle but significant luteal phase elevation during an in vitro fertilization program","volume":"43","author":"Unkila-Kallio","year":"2000","journal-title":"Am J Reprod Immunol"},{"key":"R32-20260601","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humrep\/13.3.651","article-title":"Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries","volume":"13","author":"Agrawal","year":"1998","journal-title":"Hum Reprod"},{"key":"R33-20260601","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/bjc.1998.158","article-title":"Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology","volume":"77","author":"Banks","year":"1998","journal-title":"Br J Cancer"},{"key":"R34-20260601","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/humrep\/del427","article-title":"Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF","volume":"22","author":"Manau","year":"2007","journal-title":"Hum Reprod"},{"key":"R35-20260601","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0140-6736(99)00471-7","article-title":"Vascular endothelial growth factor platelet counts, and prognosis in renal cancer","volume":"353","author":"O'Byrne","year":"1999","journal-title":"Lancet"},{"key":"R36-20260601","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jdiacomp.2016.10.020","article-title":"VEGF and the diabetic kidney: more than too much of a good thing","volume":"31","author":"Majumder","year":"2017","journal-title":"J Diabetes Complications"},{"key":"R37-20260601","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10641955.2017.1411946","article-title":"Early pregnancy protein multiplex screening reflects circulating and urinary divergences associated with the development of preeclampsia","volume":"37","author":"Martinez-Fierro","year":"2018","journal-title":"Hypertens Pregnancy"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:01:01Z","timestamp":1780326061000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004171","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2020-06-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}